Cancer

Cancer

Breakthrough in Cancer Gene Therapy: Dual-Targeting Dendrimer Gel Nanoparticles Show Promising Therapeutic Outcomes

Researchers at the Missouri University of Science and Technology have developed a new type of dendrimer gel nanoparticle that targets two key proteins in triple-negative breast cancer (TNBC) cells, urokinase-type plasminogen activator receptor (uPAR) and ribonucleotide reductase R2 (R2). This novel design allows the nanoparticles to deliver the antisense oligonucleotide